ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,841, issued on July 14.
"Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors" was invented by Peter Hewitt (Craigavon, Great Britain), Frank Burkamp (Craigavon, Great Britain), Andrew Wilkinson (Craigavon, Great Britain), Hugues Miel (Craigavon, Great Britain) and Colin O'Dowd (Craigavon, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound that is useful as an inhibitor of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising this compound and to methods of using this compound in the treatment of cancer and methods of treating cancer."
The ...